Sight Sciences Management
Management criteria checks 3/4
Sight Sciences' CEO is Paul Badawi, appointed in Jan 2011, has a tenure of 13.5 years. total yearly compensation is $3.90M, comprised of 15.6% salary and 84.4% bonuses, including company stock and options. directly owns 10.36% of the company’s shares, worth $32.53M. The average tenure of the management team and the board of directors is 4.3 years and 4.4 years respectively.
Key information
Paul Badawi
Chief executive officer
US$3.9m
Total compensation
| CEO salary percentage | 15.6% |
| CEO tenure | 13.5yrs |
| CEO ownership | 10.4% |
| Management average tenure | 4.3yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Sight Sciences, Inc. (NASDAQ:SGHT) Stock Catapults 46% Though Its Price And Business Still Lag The Industry
Dec 19
Some Analysts Just Cut Their Sight Sciences, Inc. (NASDAQ:SGHT) Estimates
Nov 19Sight Sciences Grows Portfolio Amid Reimbursement Pressure
Aug 19Sizing Up Sight Sciences
Jun 26Sight Sciences - Opening My Eyes
Apr 08Analysts Have Been Trimming Their Sight Sciences, Inc. (NASDAQ:SGHT) Price Target After Its Latest Report
Mar 26Sight Sciences: Appeal Is Visually Increasing
Jan 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$55m |
| Dec 31 2023 | US$4m | US$610k | -US$56m |
| Sep 30 2023 | n/a | n/a | -US$62m |
| Jun 30 2023 | n/a | n/a | -US$71m |
| Mar 31 2023 | n/a | n/a | -US$80m |
| Dec 31 2022 | US$6m | US$580k | -US$86m |
| Sep 30 2022 | n/a | n/a | -US$85m |
| Jun 30 2022 | n/a | n/a | -US$80m |
| Mar 31 2022 | n/a | n/a | -US$74m |
| Dec 31 2021 | US$9m | US$424k | -US$63m |
| Sep 30 2021 | n/a | n/a | -US$56m |
| Jun 30 2021 | n/a | n/a | -US$47m |
| Mar 31 2021 | n/a | n/a | -US$38m |
| Dec 31 2020 | US$497k | US$360k | -US$35m |
Compensation vs Market: Paul's total compensation ($USD3.90M) is above average for companies of similar size in the US market ($USD2.43M).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
CEO
Paul Badawi (49 yo)
13.5yrs
Tenure
US$3,902,022
Compensation
Mr. Paul Badawi is a Co-Founder of Sight Sciences, Inc. since 2011 and serves as its President and Chief Executive Officer since 2011. Mr. Badawi specializes in medical technology investments for 3i. His p...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.5yrs | US$3.90m | 10.36% $ 31.9m | |
| Founder | 13.5yrs | no data | 3.22% $ 9.9m | |
| CFO & Treasurer | 1.3yrs | US$1.85m | 0.081% $ 249.0k | |
| Chief Commercial Officer | less than a year | US$2.36m | no data | |
| Chief Operating Officer | 4.3yrs | US$1.86m | 0.12% $ 354.4k | |
| Chief Legal Officer | 4.3yrs | no data | 0.034% $ 103.7k | |
| VP and Chief Ethics & Compliance Officer | 1.2yrs | no data | no data | |
| Chief Medical Officer | 5.8yrs | no data | no data | |
| Secretary | no data | no data | no data | |
| VP of Finance & Corporate Controller | no data | no data | 0.0014% $ 4.3k |
4.3yrs
Average Tenure
51.5yo
Average Age
Experienced Management: SGHT's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.5yrs | US$3.90m | 10.36% $ 31.9m | |
| Founder | 13.5yrs | no data | 3.22% $ 9.9m | |
| Independent Director | 4.7yrs | US$182.30k | 0.22% $ 684.0k | |
| Independent Director | 4.1yrs | US$187.50k | 0.20% $ 619.6k | |
| Independent Director | 2.3yrs | US$167.33k | 0.0074% $ 22.8k | |
| Independent Chairman | 6.8yrs | US$207.91k | 4.41% $ 13.6m | |
| Independent Director | 2yrs | US$401.06k | 0.042% $ 130.5k | |
| Independent Director | 1.1yrs | US$256.34k | 0.037% $ 112.7k |
4.4yrs
Average Tenure
60yo
Average Age
Experienced Board: SGHT's board of directors are considered experienced (4.4 years average tenure).